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Multiple myeloma is a cancer of plasma cells that produce monoclonal immunoglobulin, and the neoplastic 
plasma cells typically accumulate in the bone marrow with occasional involvement of other organs. Pleural 
effusion that is associated with multiple myeloma has been infrequently reported (＜6%) and myelomatous 
pleural effusion is extremely rare (＜1%). A 73-year-old woman was admitted to the department of 
dermatology for skin lesions on both arms and both ankles. A chest radiograph taken on admission showed 
a nodular lesion in the right upper lung and pleural effusion. Analysis of the pleural fluid revealed many 
atypical plasma cells, elevated levels of IgA (27.95g/L) and lambda light chain (9.16g/L), and monoclonal 
IgA-lambda paraprotein on immunofixation. The serum concentrations of IgA were elevated (33.08g/L) 
while the concentrations of IgG and IgM were decreased. Bone marrow aspirate smears contained 
increased levels of immature-appearing atypical plasma cells. This is only the third case of myelomatous 
pleural effusion that has been reported in Korea. (Korean J Hematol 2006;41:41-45.)
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INTRODUCTION
  Multiple myeloma (MM) is a disease in which 
neoplastic plasma cells accumulate in the bone 
marrow and generally produce a monoclonal immu-
noglobulin, usually of type IgG or IgA.1) Malignant 
plasma cells may also affect other organs. Alth-
ough the involvement of rib and sternum is 
relatively common, associated pulmonary paren-
chymal or pleural disease has been reported 
infrequently.2,3) Pleural effusion in MM has been 
reported in less than 6% of cases and myeloma-
tous pleural effusion (MPE) is extremely rare 
(＜1%).4,5) MPE is most commonly associated 
with IgA or IgG myeloma and very rarely with 
IgD or light chain myeloma.6-9) Only two cases of 
MPE associated with MM have been reported in 
Korea to date: one with IgG-kappa and the other 
with IgD-lambda myeloma.3,9) The present study 
involves a patient with IgA-lambda MM who 
presented with skin lesions and pleural effusion.
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Fig. 1. Cytospin smears of pleural fluid showing clusters 
of plasma cells with marked atypia such as anisocy-
tosis, immature forms, and multinucleation (Wright-Giemsa, 
×1,000).
CASE REPORT
  A 73-year-old woman was admitted to the der-
matology department for skin lesions on both of 
her arms and ankles. She had been followed up 
in the dermatology department for 7 months for 
evaluation of erythematous macules and papules 
on her arm. Her symptoms persisted and the 
lesions spread to the lower extremities. No remark-
able findings were seen on physical examination 
other than edematous ankles with tenderness of 
the newly developed lesions. 
  Chest radiography revealed the persistence of a 
previously noted nodular lesion in the upper right 
lung and a newly developed blunting of the right 
costophrenic angle (CPA) suggestive of pleural 
effusion. Upon admission, her hemoglobin con-
centration was 106g/L (10.6g/dL; reference interval, 
120~160g/L [12.0~16.0g/dL]), white cell count 
4.86×109/L (4,860/μL; reference interval, 4.0~ 
10.8×109/L [4,000~10,800/μL]), and platelet count 
270×109/L (270×103/μL; reference interval, 150~ 
400×109/L [150~400×103/μL]). Serum creatinine, 
calcium, total protein, and albumin levels were 
70.7μmol/L (0.8mg/dL; reference interval, 44.2~ 
123.76μmol/L [0.5~1.4mg/dL]), 2.3mmol/L (9.3 
mg/dL; reference interval, 2.2~2.7mmol/L [8.7~ 
10.8mg/dL]), 84g/L (8.4g/dL; reference interval, 
58~78g/L [5.8~7.8g/dL]), and 30g/L (3.0g/dL; 
reference interval, 34~53g/L [3.4~5.3g/dL]), respec-
tively. Laboratory tests for antinuclear antibodies, 
antineutrophil cytoplasmic antibodies (ANCA), 
and cryoglobulins were negative.
  Thoracentesis was performed due to persistent 
pleural effusion, and the cytospin smears of the 
pleural fluid revealed clusters of atypical plasma 
cells, suggestive of plasmacytoma or multiple 
myeloma (Fig. 1). Quantitation of immunoglobulin 
and light chain in the pleural fluid showed 
increased concentrations of IgA (27.95g/L, 2,795 
mg/dL) and lambda light chain (9.16g/L, 916 
mg/dL). Serum protein electrophoresis revealed a 
monoclonal peak in the beta and gamma globulin 
region, with markedly elevated serum IgA (33.08 
g/L [3,308mg/dL]; reference interval, 1.0~4.9g/L 
[100~490mg/dL]) and lambda light chain (10.1g/L 
[1,010mg/dL]; reference interval, 0.9~2.1g/L [90~ 
210mg/dL]) and decreased levels of IgM (0.34g/L 
[34mg/dL]; reference interval, 0.5~3.2g/L [50~ 
320mg/dL]), IgG (5.41g/L [541mg/dL]; reference 
interval, 8.0~17.0g/L [800~1,700mg/dL]), and 
kappa light chain (1.46g/L [146mg/dL]; reference 
interval, 1.7~3.7g/L [170~370mg/dL]). Immuno-
fixation confirmed the monoclonal IgA-lambda 
chain peak. Immunofixation of the pleural fluid 
was consistent with that of serum, demonstrating 
the presence of a monoclonal IgA-lambda para-
protein. A bone marrow study was performed in 
which the bone marrow aspirate smears exhibited 
increased levels of plasma cells, with marked 
atypia such as anisocytosis, immature forms, and 
double nuclei involving 51% of all nucleated cells, 
thus substantiating the diagnosis of multiple 
myeloma (Fig. 2). 
  A punch biopsy of the leg on the second hospi-
tal day revealed leukocytoclastic vasculitis (LCV) 
with multiple fibrin thrombi. On the seventh day, 
the patient complained of swelling of the right 
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Fig. 2. Bone marrow aspiration 
and biopsy. (A) Aspiration smear
showing increased atypical plas-
ma cells with immature forms. 
(B) Biopsy section showing infil-
tration of immature plasma cells 
(A: Wright-Giemsa, ×1,000; B: He-
matoxylin and Eosin (H&E), ×400).
arm and a soft and fixed mass was incidentally 
found on the frontal scalp area. Punch biopsy of 
the scalp lesion showed mild superficial 
perivenular lymphocytic infiltration. A breast ultr-
asonogram was performed to determine the cause 
of edema, indicating multiple lymph node enlarge-
ment of the right axilla and a huge multiseptated 
mass at the right supraclavicular area, suggestive 
of a possible malignant lymphoma, metastatic 
malignant lesion, or tuberculosis. A fine needle 
aspiration biopsy of the axillary lymph node 
showed diffuse infiltration of mature and immature 
plasma cells, consistent with plasma cell myeloma. 
The right supraclavicular mass appeared malig-
nant, with possible pathologic diagnoses of extra-
osseous plasmocytoma with metastasis, malignant 
lymphoma, inflammatory reactive lymphadenopathy 
or metastatic malignancy involving lymph nodes 
from lung, breast, or stomach cancer. The follow 
up was lost because the patient was transferred to 
another hospital for further treatment.
DISCUSSION
  We report a case of late stage MM with 
associated malignant pleural effusion, leukocy-
toclastic vasculitis and lymphedema. The most 
common cause of the MM-related pleural effusion 
is congestive heart failure, due to either amyloido-
sis or atherosclerotic heart disease. Other less com-
mon causes include pulmonary embolism, chronic 
renal failure, a second neoplasm, and myelomatous 
pleural invovement.10) Malignant pleural effusion 
in MM is extremely rare, occurring in less than 
1% of patients.4) In Korea, only two cases of mye-
loma with associated MPE have been reported to 
date, one IgG-kappa and one IgD- lambda,3,9) and 
its prevalence has not been reported. In the present 
study, myelomatous effusion was diagnosed by 
detection of IgA-lambda type monoclonal immu-
noglobulin and atypical plasma cells in the pleural 
fluid. It should be noted that protein electro-
phoresis of pleural fluid may be unreliable since 
hemorrhagic effusions are common, and pleural 
biopsy may show a low diagnostic yield of plasma 
cell infiltrates due to frequent non-uniform pleural 
involvement.11) The differential diagnoses based 
on the morphology of plasma cells in pleural 
effusion include MM, lymphoma with plasma-
cytic differentiation, and metastatic non-hema-
tolymphoid neoplasia such as melanoma and 
neuroendocrine carcinoma. IgA gammopathy is 
more frequently represented in MM cases with 
MPE,12) implying a difference in propensity to 
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develop MPE according to the type of para-
protein. Pleural effusion is indicative of a dismal 
prognosis in MM and generally represents a late 
complication of progressive and disseminated 
disease.10-12) Patients with MPE usually respond 
poorly to available therapy and the mortality 
rate reaches 90% within 1 year. In a recent report 
of 11 patients who developed MPE approximately 
12 months after being diagnosed with MM, the 
median survival was 4 months from the onset of 
MPE, suggesting that MPE in MM is often asso-
ciated with a poor prognosis despite aggressive 
local and systemic treatment.12)
  LCV is an inflammatory necrotizing disease of 
the superficial dermal vessels that is associated 
with a variety of diseases including infections, 
drug reactions, connective tissue disorders, ANCA- 
associated vasculitides, as well as malignancies 
involving both solid tumors and lymphoproli-
ferative disorders.13) Since LCV has been observed 
in association with so many disease states, it has 
been difficult to clarify the relationship between 
LCV and malignancies. However, the cutaneous 
manifestation of the patient in this study may 
have been associated with late stage MM, since 
she did not have any apparent connective tissue 
disorders or ANCA-associated vasculitides. Cyto-
kine elease by tumor cells, which induces an 
immunologic reaction against vascular smooth 
muscle cells, is one of several pathogenic mecha-
nisms that have been proposed to explain this 
connection.14) It has also been suggested that 
patients with a poorer prognosis or with late stage 
MM may be predisposed towards the develop-
ment of LCV due to an increased immunologic 
response.14)
  In conclusion, recognition of the malignant 
nature of the pleural effusion is of great import-
ance for therapeutic and prognostic considera-
tions and can be achieved by cytological examina-
tion, immunoelectrophoresis, and flow cytometric 
analysis of the pleural fluid. Likewise, a screening 
examination to detect any underlying neoplasms 
may be warranted in elderly patients with appa-
rently idiopathic cutaneous LCV and clinical 
symptoms suggestive of malignancy.
요      약
  다발성골수종은 형질세포의 악성종양으로 주로 골
과 골수를 침범하여 골파괴, 골수부전, 고칼슘혈증, 신
부전, 빈번한 감염과 이상단백인 M-component 면역
글로불린을 분비하는 질환이다. 다발성골수종은 신체
의 거의 모든 장기와 조직에 골수종세포가 침투할 수 
있으며, 그 중 가장 흔히 동반되는 장기는 간, 비장, 림
프절, 신장 등이 있다. 다발성골수종에서 골수종세포
의 늑막 침범에 의한 늑막삼출 동반 예는 보고가 적다. 
저자들은 다발성골수종의 주변 림프절과 늑막 침범에 
의해 늑막삼출이 동반된 1예를 진단하고 이를 문헌고
찰과 함께 보고하는 바이다.
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